STOCKHOLDERS' EQUITY (Details - Warrants) - Warrant [Member] - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Shares outstanding at beginning | 44,644 | ||
| Weighted average exercise price, outstanding beginning balance | $ 7.70 | ||
| Weighted average remaining contractual term (years) | 8 months 12 days | ||
| Aggregate intrinsic value, outstanding beginning balance | |||
| Number of warrants, warrants expired, forfeited, cancelled or exercised | (344,644) | ||
| Weighted average exercise price, warrants expired, forfeited, cancelled or exercised | |||
| Number of warrants, warrants issued | 300,000 | ||
| Weighted average exercise price, warrants issued | $ 3.00 | ||
| Shares outstanding at end | 44,644 | ||
| Weighted average exercise price, outstanding ending balance | $ 7.70 | ||
| Aggregate intrinsic value, outstanding ending balance | |||
| Number of warrants, exercisable | 44,644 | ||
| Weighted average exercise price, exercisable | $ 7.70 | ||
| Aggregate intrinsic value, exercisable | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|